1 - 5 toradh á dtaispeáint as 5 toradh san iomlán ar an gcuardach 'Seyed Reza Mousavi (13223324)', am iarratais: 0.01s Beachtaigh na torthaí
  1. 1
    The non-inferiority margin in Phase III clinical trial of SnaFab compared to Razi antivenom in snakebites.

    The non-inferiority margin in Phase III clinical trial of SnaFab compared to Razi antivenom in snakebites. de réir Seyed Reza Mousavi (13223324)

    Foilsithe / Cruthaithe 2025
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    Snakebite severity classification in clinical trial of SnaFab vs. Razi antivenom in snakebite victims [14,57,58].

    Snakebite severity classification in clinical trial of SnaFab vs. Razi antivenom in snakebite victims [14,57,58]. de réir Seyed Reza Mousavi (13223324)

    Foilsithe / Cruthaithe 2025
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    Adverse events during follow-up period in Phase III non-inferiority clinical trial of SnaFab compared to Razi antivenom in snakebites.

    Adverse events during follow-up period in Phase III non-inferiority clinical trial of SnaFab compared to Razi antivenom in snakebites. de réir Seyed Reza Mousavi (13223324)

    Foilsithe / Cruthaithe 2025
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    Consort Chart of Phase III clinical trial of SnaFab compare to Razi antivenom in snakebites.

    Consort Chart of Phase III clinical trial of SnaFab compare to Razi antivenom in snakebites. de réir Seyed Reza Mousavi (13223324)

    Foilsithe / Cruthaithe 2025
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    Demographic information and clinical presentation of victims in Phase III non-inferiority clinical trial of SnaFab compare to Razi antivenom in snakebites.

    Demographic information and clinical presentation of victims in Phase III non-inferiority clinical trial of SnaFab compare to Razi antivenom in snakebites. de réir Seyed Reza Mousavi (13223324)

    Foilsithe / Cruthaithe 2025
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: